An updated meta-analysis of randomized controlled trials (RCTs) examining continuous (CS) versus intermittent strategies (IS) of delivering systemic treatment (Tx) for untreated metastatic colorectal cancer (mCRC).

Suneil Kumar Khanna,Nazik Hammad,Timothy R Asmis,Roxanne Cosby,Monika K Krzyzanowska,Scott R Berry,Kelvin K Chan

doi:10.1200/jco.2015.33.15_suppl.e14641

An updated meta-analysis of randomized controlled trials (RCTs) examining continuous (CS) versus intermittent strategies (IS) of delivering systemic treatment (Tx) for untreated metastatic colorectal cancer (mCRC).

Suneil Kumar Khanna, Nazik Hammad + Show 5 more

https://doi.org/10.1200/jco.2015.33.15_suppl.e14641

Copy DOI

Export

Save

Cite

Journal: Journal of Clinical Oncology

Publication Date: May 20, 2015

Affiliation: Sunnybrook Health Science Centre, Queen's University, Ottawa Regional Cancer Foundation, McMaster University, Princess Margaret Cancer Centre, Health Sciences Centre, University of Toronto

#Continuous #Intermittent Strategies #Systemic Treatment For Cancer #Treatment For Metastatic Colorectal Cancer #Randomized Controlled Trials #Treatment For Colorectal Cancer #Untreated Cancer #Treatment For Cancer #Untreated Metastatic Colorectal Cancer #Median Life Expectancy

Abstract
Full-Text
Similar Papers

Abstract

Listen

e14641 Background: The median life expectancy for unresectable mCRC is now 30 months. Traditionally, CS are used to treat mCRC; however, to reduce treatment-related toxicity, IS have been developed...

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

An updated meta-analysis of randomized controlled trials (RCTs) examining continuous (CS) versus intermittent strategies (IS) of delivering systemic treatment (Tx) for untreated metastatic colorectal cancer (mCRC).